Literature DB >> 27232975

c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.

Rachel M DeRita1,2, Brad Zerlanko1,2, Amrita Singh1,2, Huimin Lu1,2, Renato V Iozzo3, Jeffrey L Benovic4, Lucia R Languino1,2.   

Abstract

It is well known that Src tyrosine kinase, insulin-like growth factor 1 receptor (IGF-IR), and focal adhesion kinase (FAK) play important roles in prostate cancer (PrCa) development and progression. Src, which signals through FAK in response to integrin activation, has been implicated in many aspects of tumor biology, such as cell proliferation, metastasis, and angiogenesis. Furthermore, Src signaling is known to crosstalk with IGF-IR, which also promotes angiogenesis. In this study, we demonstrate that c-Src, IGF-IR, and FAK are packaged into exosomes (Exo), c-Src in particular being highly enriched in Exo from the androgen receptor (AR)-positive cell line C4-2B and AR-negative cell lines PC3 and DU145. Furthermore, we show that the active phosphorylated form of Src (SrcpY416 ) is co-expressed in Exo with phosphorylated FAK (FAKpY861 ), a known target site of Src, which enhances proliferation and migration. We further demonstrate for the first time exosomal enrichment of G-protein-coupled receptor kinase (GRK) 5 and GRK6, both of which regulate Src and IGF-IR signaling and have been implicated in cancer. Finally, SrcpY416 and c-Src are both expressed in Exo isolated from the plasma of prostate tumor-bearing TRAMP mice, and those same mice have higher levels of exosomal c-Src than their wild-type counterparts. In summary, we provide new evidence that active signaling molecules relevant to PrCa are enriched in Exo, and this suggests that the Src signaling network may provide useful biomarkers detectable by liquid biopsy, and may contribute to PrCa progression via Exo. J. Cell. Biochem. 118: 66-73, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  EXOSOMES; FOCAL ADHESION KINASE; G-PROTEIN-COUPLED RECEPTOR KINASE; PROSTATE CANCER; SIGNALING; Src; VESICLES

Mesh:

Substances:

Year:  2016        PMID: 27232975      PMCID: PMC5552241          DOI: 10.1002/jcb.25611

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  52 in total

Review 1.  The IGF-1 receptor in cancer biology.

Authors:  Renato Baserga; Francesca Peruzzi; Krysztof Reiss
Journal:  Int J Cancer       Date:  2003-12-20       Impact factor: 7.396

2.  Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.

Authors:  Ikrame Lazar; Emily Clement; Manuelle Ducoux-Petit; Laurence Denat; Vanessa Soldan; Stéphanie Dauvillier; Stéphanie Balor; Odile Burlet-Schiltz; Lionel Larue; Catherine Muller; Laurence Nieto
Journal:  Pigment Cell Melanoma Res       Date:  2015-05-30       Impact factor: 4.693

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 4.  Mechanisms of apoptosis by the tumor suppressor Par-4.

Authors:  Nikhil Hebbar; Chi Wang; Vivek M Rangnekar
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

5.  Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.

Authors:  Jung Eun Park; Hon Sen Tan; Arnab Datta; Ruenn Chai Lai; Huoming Zhang; Wei Meng; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2010-02-01       Impact factor: 5.911

Review 6.  Angiogenesis and prostate cancer tumor growth.

Authors:  Brian Nicholson; Dan Theodorescu
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

7.  SRC family kinase activity is up-regulated in hormone-refractory prostate cancer.

Authors:  Oleg Tatarov; Thomas J Mitchell; Morag Seywright; Hing Y Leung; Valerie G Brunton; Joanne Edwards
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

8.  Exosomes released from breast cancer carcinomas stimulate cell movement.

Authors:  Dinari A Harris; Sajni H Patel; Marjan Gucek; An Hendrix; Wendy Westbroek; Justin W Taraska
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Identification of prostate cancer biomarkers in urinary exosomes.

Authors:  Anders Øverbye; Tore Skotland; Christian J Koehler; Bernd Thiede; Therese Seierstad; Viktor Berge; Kirsten Sandvig; Alicia Llorente
Journal:  Oncotarget       Date:  2015-10-06

10.  IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels.

Authors:  Aejaz Sayeed; Carmine Fedele; Marco Trerotola; Kirat K Ganguly; Lucia R Languino
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more
  44 in total

1.  Role of Src/FAK in migration and invasion mediated by extracellular vesicles from MDA-MB-231 cells stimulated with linoleic acid.

Authors:  Javier Ramirez-Ricardo; Elizabeth Leal-Orta; Alejandra Garcia-Hernandez; Ricardo Diaz-Aragon; Pedro Cortes-Reynosa; Rocio Thompson-Bonilla; Eduardo Perez Salazar
Journal:  Med Oncol       Date:  2021-03-16       Impact factor: 3.064

Review 2.  Exosomes in Toxicology: Relevance to Chemical Exposure and Pathogenesis of Environmentally Linked Diseases.

Authors:  Dilshan S Harischandra; Shivani Ghaisas; Dharmin Rokad; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

3.  Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.

Authors:  Shiv Ram Krishn; Amrita Singh; Nicholas Bowler; Alexander N Duffy; Andrea Friedman; Carmine Fedele; Senem Kurtoglu; Sushil K Tripathi; Kerith Wang; Adam Hawkins; Aejaz Sayeed; Chirayu P Goswami; Madhukar L Thakur; Renato V Iozzo; Stephen C Peiper; William K Kelly; Lucia R Languino
Journal:  Matrix Biol       Date:  2018-08-08       Impact factor: 11.583

Review 4.  Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy.

Authors:  Ahmed Elsherbini; Erhard Bieberich
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

Review 5.  The role of G protein-coupled receptor kinases in the pathology of malignant tumors.

Authors:  Wu-Yi Sun; Jing-Jing Wu; Wen-Ting Peng; Jia-Chang Sun; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

6.  Convergence of eicosanoid and integrin biology: Role of Src in 12-LOX activation.

Authors:  Ashok-Kumar Dilly; Keqin Tang; Yande Guo; Sangeeta Joshi; Prasanna Ekambaram; Krishna Rao Maddipati; Yinlong Cai; Stephanie C Tucker; Kenneth V Honn
Journal:  Exp Cell Res       Date:  2016-12-20       Impact factor: 3.905

Review 7.  Exosomes and cancer: from molecular mechanisms to clinical applications.

Authors:  Ameneh Jafari; Amirhesam Babajani; Meghdad Abdollahpour-Alitappeh; Nayebali Ahmadi; Mostafa Rezaei-Tavirani
Journal:  Med Oncol       Date:  2021-03-20       Impact factor: 3.064

8.  Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.

Authors:  Madhav Madurantakam Royam; Chellan Kumarasamy; Siddhartha Baxi; Ajay Gupta; Nachimuthu Ramesh; Gothandam Kodiveri Muthukaliannan; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

9.  A Fyn biosensor reveals pulsatile, spatially localized kinase activity and signaling crosstalk in live mammalian cells.

Authors:  Ananya Mukherjee; Randhir Singh; Sreeram Udayan; Sayan Biswas; Pothula Purushotham Reddy; Saumya Manmadhan; Geen George; Shilpa Kumar; Ranabir Das; Balaji M Rao; Akash Gulyani
Journal:  Elife       Date:  2020-02-04       Impact factor: 8.140

10.  Full-length antibodies versus single-chain antibody fragments for a selective impedimetric lectin-based glycoprofiling of prostate specific antigen.

Authors:  Stefan Belicky; Pavel Damborsky; Julia Zapatero-Rodríguez; Richard O'Kennedy; Jan Tkac
Journal:  Electrochim Acta       Date:  2017-08-20       Impact factor: 6.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.